Cargando…

Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()

PURPOSE: The monocyte-to-lymphocyte ratio (MLR) has been shown to be associated with the prognosis of various solid tumors. This study sought to evaluate the important value of the MLR in ovarian cancer patients. METHODS: A total of 133 ovarian cancer patients and 43 normal controls were retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Jiangdong, Zhou, Lina, Li, Xing, Bao, Wei, Chen, Taizhong, Xi, Xiaowei, He, Yinyan, Wan, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124360/
https://www.ncbi.nlm.nih.gov/pubmed/27888711
http://dx.doi.org/10.1016/j.tranon.2016.10.006
_version_ 1782469852583165952
author Xiang, Jiangdong
Zhou, Lina
Li, Xing
Bao, Wei
Chen, Taizhong
Xi, Xiaowei
He, Yinyan
Wan, Xiaoping
author_facet Xiang, Jiangdong
Zhou, Lina
Li, Xing
Bao, Wei
Chen, Taizhong
Xi, Xiaowei
He, Yinyan
Wan, Xiaoping
author_sort Xiang, Jiangdong
collection PubMed
description PURPOSE: The monocyte-to-lymphocyte ratio (MLR) has been shown to be associated with the prognosis of various solid tumors. This study sought to evaluate the important value of the MLR in ovarian cancer patients. METHODS: A total of 133 ovarian cancer patients and 43 normal controls were retrospectively reviewed. The patients' demographics were analyzed along with clinical and pathologic data. The counts of peripheral neutrophils, lymphocytes, monocytes, and platelets were collected and used to calculate the MLR, neutrophil-to-lymphocyte ratio (NLR). and platelet-to-lymphocyte ratio (PLR). The optimal cutoff value of the MLR was determined by using receiver operating characteristic curve analysis. We compared the MLR, NLR, and PLR between ovarian cancer and normal control patients and among patients with different stages and different grades, as well as between patients with lymph node metastasis and non–lymph node metastasis. We then investigated the value of the MLR in predicting the stage, grade, and lymph node positivity by using logistic regression. The impact of the MLR on overall survival (OS) was calculated by Kaplan-Meier method and compared by log-rank test. RESULTS: Statistically significant differences in the MLR were observed between ovarian cancer patients and normal controls. However, no difference was found for the NLR and PLR. Highly significant differences in the MLR were found among patients with different stages (stage I-II and stage III-IV), grades (G1 and >G1), and lymph node metastasis status. The MLR was a significant and independent risk factor for lymph node metastasis, as determined by logistic regression. The optimal cutoff value of the MLR was 0.23. We also classified the data according to tumor markers (CA125, CA199, HE4, AFP, and CEA) and conventional coagulation parameters (International Normalized Ratio [INR] and fibrinogen). Highly significant differences in CA125, CA199, HE4, INR, fibrinogen levels, and lactate dehydrogenase were found between the low-MLR group (MLR ≤ 0.23) and the high-MLR group (MLR > 0.23). Correspondingly, dramatic differences were observed between the two groups in OS. CONCLUSION: Our results show that the peripheral blood MLR before surgery could be a significant predictor of advanced stages, advanced pathologic grades, and positive lymphatic metastasis in ovarian cancer patients.
format Online
Article
Text
id pubmed-5124360
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-51243602016-11-30 Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()() Xiang, Jiangdong Zhou, Lina Li, Xing Bao, Wei Chen, Taizhong Xi, Xiaowei He, Yinyan Wan, Xiaoping Transl Oncol Original article PURPOSE: The monocyte-to-lymphocyte ratio (MLR) has been shown to be associated with the prognosis of various solid tumors. This study sought to evaluate the important value of the MLR in ovarian cancer patients. METHODS: A total of 133 ovarian cancer patients and 43 normal controls were retrospectively reviewed. The patients' demographics were analyzed along with clinical and pathologic data. The counts of peripheral neutrophils, lymphocytes, monocytes, and platelets were collected and used to calculate the MLR, neutrophil-to-lymphocyte ratio (NLR). and platelet-to-lymphocyte ratio (PLR). The optimal cutoff value of the MLR was determined by using receiver operating characteristic curve analysis. We compared the MLR, NLR, and PLR between ovarian cancer and normal control patients and among patients with different stages and different grades, as well as between patients with lymph node metastasis and non–lymph node metastasis. We then investigated the value of the MLR in predicting the stage, grade, and lymph node positivity by using logistic regression. The impact of the MLR on overall survival (OS) was calculated by Kaplan-Meier method and compared by log-rank test. RESULTS: Statistically significant differences in the MLR were observed between ovarian cancer patients and normal controls. However, no difference was found for the NLR and PLR. Highly significant differences in the MLR were found among patients with different stages (stage I-II and stage III-IV), grades (G1 and >G1), and lymph node metastasis status. The MLR was a significant and independent risk factor for lymph node metastasis, as determined by logistic regression. The optimal cutoff value of the MLR was 0.23. We also classified the data according to tumor markers (CA125, CA199, HE4, AFP, and CEA) and conventional coagulation parameters (International Normalized Ratio [INR] and fibrinogen). Highly significant differences in CA125, CA199, HE4, INR, fibrinogen levels, and lactate dehydrogenase were found between the low-MLR group (MLR ≤ 0.23) and the high-MLR group (MLR > 0.23). Correspondingly, dramatic differences were observed between the two groups in OS. CONCLUSION: Our results show that the peripheral blood MLR before surgery could be a significant predictor of advanced stages, advanced pathologic grades, and positive lymphatic metastasis in ovarian cancer patients. Neoplasia Press 2016-11-24 /pmc/articles/PMC5124360/ /pubmed/27888711 http://dx.doi.org/10.1016/j.tranon.2016.10.006 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Xiang, Jiangdong
Zhou, Lina
Li, Xing
Bao, Wei
Chen, Taizhong
Xi, Xiaowei
He, Yinyan
Wan, Xiaoping
Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title_full Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title_fullStr Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title_full_unstemmed Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title_short Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer()()
title_sort preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer()()
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124360/
https://www.ncbi.nlm.nih.gov/pubmed/27888711
http://dx.doi.org/10.1016/j.tranon.2016.10.006
work_keys_str_mv AT xiangjiangdong preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT zhoulina preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT lixing preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT baowei preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT chentaizhong preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT xixiaowei preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT heyinyan preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer
AT wanxiaoping preoperativemonocytetolymphocyteratioinperipheralbloodpredictsstagesmetastasisandhistologicalgradesinpatientswithovariancancer